{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T03:49:02Z","timestamp":1790480942036,"version":"4.1.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,11,28]],"date-time":"2016-11-28T00:00:00Z","timestamp":1480291200000},"content-version":"am","delay-in-days":393,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100008871","name":"Juvenile Diabetes Research Foundation United States of America","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Immunology"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1016\/j.cellimm.2015.09.003","type":"journal-article","created":{"date-parts":[[2015,9,7]],"date-time":"2015-09-07T13:50:15Z","timestamp":1441633815000},"page":"54-65","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["HLA-DR*0401 expression in the NOD mice prevents the development of autoimmune diabetes by multiple alterations in the T-cell compartment"],"prefix":"10.1016","volume":"298","author":[{"given":"Luis","family":"Pow Sang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline","family":"Surls","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirian","family":"Mendoza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Casares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teodor","family":"Brumeanu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.cellimm.2015.09.003_b0005","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S1074-7613(01)00202-3","article-title":"Genetic protection from the inflammatory disease type 1 diabetes in humans and animal models","volume":"15","author":"Todd","year":"2001","journal-title":"Immunity"},{"issue":"6","key":"10.1016\/j.cellimm.2015.09.003_b0010","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s11892-011-0223-x","article-title":"Genetics of the HLA region in the prediction of type 1 diabetes","volume":"11","author":"Noble","year":"2011","journal-title":"Curr. Diab.Rep."},{"issue":"1","key":"10.1016\/j.cellimm.2015.09.003_b0015","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1146\/annurev.iy.09.040191.002425","article-title":"MHC class-II molecules and autoimmunity","volume":"9","author":"Nepom","year":"1991","journal-title":"Ann. Rev. Immunol."},{"issue":"5","key":"10.1016\/j.cellimm.2015.09.003_b0020","first-page":"1134","article-title":"The role of HLA class II genes in insulin-dependent diabetes mellitus: molecular analysis of 180 Caucasian, multiplex families","volume":"59","author":"Noble","year":"1996","journal-title":"Am. J. Hum. Genet."},{"issue":"8","key":"10.1016\/j.cellimm.2015.09.003_b0025","doi-asserted-by":"crossref","first-page":"4037","DOI":"10.1210\/jc.2003-032084","article-title":"Absolute risk of childhood-onset type 1 diabetes defined by human leukocyte antigen class II genotype: a population-based study in the United Kingdom","volume":"89","author":"Lambert","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"9","key":"10.1016\/j.cellimm.2015.09.003_b0030","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1002\/eji.200526158","article-title":"Soluble, dimeric HLA DR4-peptide chimeras: an approach for detection and immunoregulation of human type-1 diabetes","volume":"35","author":"Preda","year":"2005","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.cellimm.2015.09.003_b0035","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/j.1399-0039.2006.00772.x","article-title":"14th International HLA and Immunogenetics Workshop Report on the HLA component of type 1 diabetes","volume":"69","author":"Steenkiste","year":"2007","journal-title":"Tissue Antigens"},{"issue":"4","key":"10.1016\/j.cellimm.2015.09.003_b0040","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/0198-8859(88)90064-X","article-title":"Analysis of DR and DQ gene products of the DR4 haplotype in patients with IDDM: possible involvement of more than one locus","volume":"23","author":"Monos","year":"1988","journal-title":"Hum. Immunol."},{"issue":"3","key":"10.1016\/j.cellimm.2015.09.003_b0045","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1172\/JCI113965","article-title":"A diabetes-susceptible HLA haplotype is best defined by a combination of HLA-DR and -DQ alleles","volume":"83","author":"Sheehy","year":"1989","journal-title":"J. Clin. Investig."},{"issue":"2","key":"10.1016\/j.cellimm.2015.09.003_b0050","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jaut.2010.12.004","article-title":"Differences in self-peptide binding between T1D-related susceptible and protective DR4 subtypes","volume":"36","author":"Ge","year":"2011","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.cellimm.2015.09.003_b0055","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/j.1600-065X.1999.tb01377.x","article-title":"HLA class II transgenic mice: models of the human CD4+ T-cell immune response","volume":"172","author":"Sonderstrup","year":"1999","journal-title":"Immunol. Rev."},{"issue":"6","key":"10.1016\/j.cellimm.2015.09.003_b0060","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1084\/jem.175.6.1707","article-title":"Species specificity and augmentation of responses to class II major histocompatibility complex molecules in human CD4 transgenic mice","volume":"175","author":"Barzaga-Gilbert","year":"1992","journal-title":"J. Exp. Med."},{"issue":"4","key":"10.1016\/j.cellimm.2015.09.003_b0065","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1084\/jem.175.4.925","article-title":"Species-specific binding of CD4 to the beta 2 domain of major histocompatibility complex class II molecules","volume":"175","author":"Vignali","year":"1992","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/j.cellimm.2015.09.003_b0070","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1084\/jem.180.1.165","article-title":"Functional interaction between human histocompatibility leukocyte antigen (HLA) class II and mouse CD4 molecule in antigen recognition by T cells in HLA-DR and DQ transgenic mice","volume":"180","author":"Yamamoto","year":"1994","journal-title":"J. Exp. Med."},{"issue":"5","key":"10.1016\/j.cellimm.2015.09.003_b0075","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1084\/jem.180.5.1911","article-title":"Human CD4-major histocompatibility complex class II (DQw6) transgenic mice in an endogenous CD4\/CD8-deficient background: reconstitution of phenotype and human-restricted function","volume":"180","author":"Yeung","year":"1994","journal-title":"J. Exp. Med."},{"issue":"4","key":"10.1016\/j.cellimm.2015.09.003_b0080","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1002\/j.1460-2075.1993.tb05798.x","article-title":"Regulated expression of human CD4 rescues helper T cell development in mice lacking expression of endogenous CD4","volume":"12","author":"Killeen","year":"1993","journal-title":"EMBO J."},{"issue":"6","key":"10.1016\/j.cellimm.2015.09.003_b0085","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1084\/jem.183.6.2635","article-title":"HLA-DR4-IE chimeric class II transgenic, murine class II-deficient mice are susceptible to experimental allergic encephalomyelitis","volume":"183","author":"Ito","year":"1996","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/j.cellimm.2015.09.003_b0090","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1084\/jem.180.1.173","article-title":"Human major histocompatibility complex class II-restricted T cell responses in transgenic mice","volume":"180","author":"Woods","year":"1994","journal-title":"J. Exp. Med."},{"issue":"6","key":"10.1016\/j.cellimm.2015.09.003_b0095","doi-asserted-by":"crossref","first-page":"e38733","DOI":"10.1371\/journal.pone.0038733","article-title":"Increased membrane cholesterol in lymphocytes diverts T-cells toward an inflammatory response","volume":"7","author":"Surls","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.cellimm.2015.09.003_b0100","doi-asserted-by":"crossref","first-page":"64","DOI":"10.2174\/1876894600901010064","article-title":"Thymic development of Foxp3+ T regulatory cells","volume":"1","author":"Nazarov-Stoica","year":"2009","journal-title":"J. Open Autoimmun."},{"issue":"10","key":"10.1016\/j.cellimm.2015.09.003_b0105","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.2337\/diabetes.48.10.1937","article-title":"Identification of peptides from autoantigens GAD65 and IA-2 that bind to HLA class II molecules predisposing to or protecting from type 1 diabetes","volume":"48","author":"Harfouch-Hammoud","year":"1999","journal-title":"Diabetes"},{"issue":"11","key":"10.1016\/j.cellimm.2015.09.003_b0110","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1172\/JCI119079","article-title":"Naturally processed T cell epitopes from human glutamic acid decarboxylase identified using mice transgenic for the type 1 diabetes-associated human MHC class II allele, DRB1*0401","volume":"98","author":"Wicker","year":"1996","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.cellimm.2015.09.003_b0115","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1146\/annurev.immunol.23.021704.115643","article-title":"The NOD Mouse: a model of immune dysregulation","volume":"23","author":"Anderson","year":"2005","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.cellimm.2015.09.003_b0120","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1146\/annurev.iy.13.040195.001143","article-title":"Genetic control of autoimmune diabetes in the NOD Mouse","volume":"13","author":"Wicker","year":"1995","journal-title":"Annu. Rev. Immunol."},{"issue":"6216","key":"10.1016\/j.cellimm.2015.09.003_b0125","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/338591a0","article-title":"The generation of mature T cells requires interaction of the \u03b1\u03b2 T-cell receptor with major histocompatibility antigens","volume":"338","author":"Scott","year":"1989","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.cellimm.2015.09.003_b0130","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.cell.2005.05.013","article-title":"How the T cell repertoire becomes peptide and MHC specific","volume":"122","author":"Huseby","year":"2005","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.cellimm.2015.09.003_b0135","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/ni770","article-title":"Down-regulation of diabetogenic CD4+ T cells by a soluble dimeric peptide-MHC class II chimera","volume":"3","author":"Casares","year":"2002","journal-title":"Nat. Immunol."},{"issue":"8","key":"10.1016\/j.cellimm.2015.09.003_b0140","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1002\/eji.200940094","article-title":"Reversal of type 1 diabetes by a new MHC II-peptide chimera: \u201cSingle-epitope-mediated suppression\u201d to stabilize a polyclonal autoimmune T-cell process","volume":"40","author":"Lin","year":"2010","journal-title":"Eur. J. Immunol."},{"issue":"2","key":"10.1016\/j.cellimm.2015.09.003_b0145","doi-asserted-by":"crossref","first-page":"306","DOI":"10.2337\/diabetes.54.2.306","article-title":"Antigen-specific FoxP3-transduced T-cells can control established type 1 diabetes","volume":"54","author":"Jaeckel","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.cellimm.2015.09.003_b0150","doi-asserted-by":"crossref","DOI":"10.1111\/pedi.12029","article-title":"Clinical application of regulatory T cells in type 1 diabetes","author":"Marek-Trzonkowska","year":"2013","journal-title":"Pediatr. Diab."},{"issue":"1\u20132","key":"10.1016\/j.cellimm.2015.09.003_b0155","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.cyto.2006.04.006","article-title":"IL-10-deficiency unmasks unique immune system defects and reveals differential regulation of organ-specific autoimmunity in non-obese diabetic mice","volume":"34","author":"Rajagopalan","year":"2006","journal-title":"Cytokine"},{"issue":"7","key":"10.1016\/j.cellimm.2015.09.003_b0160","doi-asserted-by":"crossref","first-page":"e11427","DOI":"10.1371\/journal.pone.0011427","article-title":"Double negative (CD3+4\u22128\u2212) TCR\u03b1\u03b2 splenic cells from young NOD Mice provide long-lasting protection against type 1 diabetes","volume":"5","author":"Duncan","year":"2010","journal-title":"PLoS ONE"},{"issue":"6","key":"10.1016\/j.cellimm.2015.09.003_b0165","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/BF00345966","article-title":"Genetic control of T-cell subset representation in inbred mice","volume":"18","author":"Kraal","year":"1983","journal-title":"Immunogenetics"},{"issue":"12","key":"10.1016\/j.cellimm.2015.09.003_b0170","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1038\/nm1295-1279","article-title":"Genetic control of the CD4\/CD8 T-cell ratio in humans","volume":"1","author":"Amadori","year":"1995","journal-title":"Nat. Med."},{"issue":"6","key":"10.1016\/j.cellimm.2015.09.003_b0175","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.4049\/jimmunol.163.6.2983","article-title":"A dominant role for the thymus and MHC genes in determining the peripheral CD4\/CD8 T cell ratio in the rat","volume":"163","author":"Damoiseaux","year":"1999","journal-title":"J. Immunol."},{"issue":"12","key":"10.1016\/j.cellimm.2015.09.003_b0180","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/S0960-9822(98)70276-3","article-title":"Thymic skewing of the CD4\/CD8 ratio maps with the T-cell receptor alpha-chain locus","volume":"8","author":"Sim","year":"1998","journal-title":"Curr. Biol."},{"issue":"1","key":"10.1016\/j.cellimm.2015.09.003_b0185","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ajhg.2009.12.008","article-title":"Quantitative trait loci for CD4:CD8 lymphocyte ratio are associated with risk of type 1 diabetes and HIV-1 immune control","volume":"86","author":"Ferreira","year":"2010","journal-title":"Am. J. Hum. Genet."},{"issue":"3","key":"10.1016\/j.cellimm.2015.09.003_b0190","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/0092-8674(89)90439-X","article-title":"Transgenic HLA-DR alpha faithfully reconstitutes IE-controlled immune functions and induces cross-tolerance to E alpha in E alpha 0 mutant mice","volume":"58","author":"Lawrance","year":"1989","journal-title":"Cell"},{"issue":"12","key":"10.1016\/j.cellimm.2015.09.003_b0195","doi-asserted-by":"crossref","first-page":"6731","DOI":"10.4049\/jimmunol.1000295","article-title":"Impact of TCR reactivity and HLA phenotype on naive CD8 T cell frequency in humans","volume":"184","author":"Legoux","year":"2010","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.cellimm.2015.09.003_b0200","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1084\/jem.174.5.1139","article-title":"T cell receptor V-segment frequencies in peripheral blood T cells correlate with human leukocyte antigen type","volume":"174","author":"Gulwani-Akolkar","year":"1991","journal-title":"J. Exp. Med."},{"issue":"11","key":"10.1016\/j.cellimm.2015.09.003_b0205","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/S0198-8859(02)00435-4","article-title":"Modulation of insulitis and type 1 diabetes by transgenic HLA-DR3 and DQ8 in NOD mice lacking endogenous MHC class II","volume":"63","author":"Kudva","year":"2002","journal-title":"Hum. Immunol."},{"issue":"9","key":"10.1016\/j.cellimm.2015.09.003_b0210","doi-asserted-by":"crossref","first-page":"4568","DOI":"10.1128\/jvi.64.9.4568-4572.1990","article-title":"Segregation patterns of endogenous mouse mammary tumor viruses in five recombinant inbred strain sets","volume":"64","author":"Lee","year":"1990","journal-title":"J. Virol."},{"issue":"5","key":"10.1016\/j.cellimm.2015.09.003_b0215","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1084\/jem.182.5.1493","article-title":"The use of mammary tumor virus (Mtv)-negative and single-Mtv mice to evaluate the effects of endogenous viral superantigens on the T cell repertoire","volume":"182","author":"Scherer","year":"1995","journal-title":"J. Exp. Med."},{"issue":"7","key":"10.1016\/j.cellimm.2015.09.003_b0220","doi-asserted-by":"crossref","first-page":"5473","DOI":"10.1128\/jvi.71.7.5473-5480.1997","article-title":"Immunogenicity of a contiguous T-B synthetic epitope of the A\/PR\/8\/34 influenza virus","volume":"71","author":"Brumeanu","year":"1997","journal-title":"J. Virol."},{"key":"10.1016\/j.cellimm.2015.09.003_b0225","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1172\/JCI11708","article-title":"The regulatory role of DR4 in a spontaneous diabetes DQ8 transgenic model","volume":"107","author":"Wen","year":"2001","journal-title":"J. Clin. Investig."},{"issue":"3","key":"10.1016\/j.cellimm.2015.09.003_b0230","first-page":"1","article-title":"Long-term silencing of autoimmune diabetes and improved life expectancy by a soluble pHLA-DR4 chimera in a newly-humanized NOD\/DR4\/B7 mouse","volume":"10","author":"Pow Sang","year":"2013","journal-title":"Hum. Vacc. Immunother."}],"container-title":["Cellular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008874915300150?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008874915300150?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T22:53:52Z","timestamp":1757804032000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0008874915300150"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":46,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["S0008874915300150"],"URL":"https:\/\/doi.org\/10.1016\/j.cellimm.2015.09.003","relation":{},"ISSN":["0008-8749"],"issn-type":[{"value":"0008-8749","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"HLA-DR*0401 expression in the NOD mice prevents the development of autoimmune diabetes by multiple alterations in the T-cell compartment","name":"articletitle","label":"Article Title"},{"value":"Cellular Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellimm.2015.09.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}